<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 15.6: Neuro-inflammation & The Blood-Brain Barrier (BBB) Interface</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - PURPLE theme for PNI/Neuro */
        .module-header {
            background: linear-gradient(135deg, #4c1d95 0%, #7c3aed 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #7c3aed;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #7c3aed;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #7c3aed;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f5f3ff;
            border: 2px solid #7c3aed;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #4c1d95;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #4c1d95;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #6d28d9;
            margin: 30px 0 15px 0;
            font-weight: 600;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e9d5ff 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        .stat-highlight {
            font-weight: 700;
            color: #7c3aed;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e5e7eb;
        }

        .case-study-header {
            background: linear-gradient(135deg, #4c1d95 0%, #7c3aed 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: #7c3aed;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Data Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f3f4f6;
            padding: 15px;
            font-weight: 600;
            color: #4c1d95;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #eee;
            vertical-align: top;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #7c3aed;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f3f4f6;
            border-radius: 8px;
            border-left: 4px solid #7c3aed;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f9fafb;
            padding: 30px;
            border-radius: 14px;
            border: 1px solid #e5e7eb;
            margin: 40px 0;
        }

        .references-box {
            background: #ffffff;
            padding: 30px;
            border-radius: 14px;
            border-top: 4px solid #4c1d95;
            margin: 40px 0;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #4c1d95;
            margin-top: 0;
        }

        .references-box ul {
            list-style: none;
            padding: 0;
        }

        .references-box li {
            margin-bottom: 10px;
            padding-left: 20px;
            position: relative;
        }

        .references-box li::before {
            content: 'â€¢';
            position: absolute;
            left: 0;
            color: #7c3aed;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.8;
            margin-bottom: 10px;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 15: Advanced Immunomodulation & The PNI Axis</p>
            <h1 class="lesson-title">Lesson 15.6: Neuro-inflammation & The Blood-Brain Barrier (BBB) Interface</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 6 of 8</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The BBB: The Fortress Under Siege</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Microglial Activation & Priming</a></li>
                <li><a href="#section3"><span class="section-num">3</span>The Kynurenine Pathway Shunt</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Biomarkers of "Leaky Brain"</a></li>
                <li><a href="#section5"><span class="section-num">5</span>The Glymphatic Waste System</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Clinical Protocols: The B.R.I.D.G.E. Framework</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the pathophysiology of Blood-Brain Barrier (BBB) permeability and its relationship to systemic inflammation.</li>
                <li>Distinguish between homeostatic and activated microglial states (M1 vs. M2 polarization).</li>
                <li>Explain the biochemical "Tryptophan Steal" and the production of neurotoxic kynurenine metabolites.</li>
                <li>Evaluate clinical biomarkers (S100B, Zonulin) to assess CNS integrity.</li>
                <li>Implement lifestyle and nutritional strategies to optimize glymphatic clearance and neuro-immunological health.</li>
            </ul>
        </div>

        <h2 id="section1">1. The BBB: The Fortress Under Siege</h2>
        <p>For decades, the central nervous system (CNS) was considered an "immunologically privileged" site, completely sequestered from the peripheral immune system. We now know this is a dangerous oversimplification. The <span class="highlight">Blood-Brain Barrier (BBB)</span> is not a static wall, but a dynamic, semi-permeable interface composed of endothelial cells, pericytes, and astrocyte end-feet.</p>

        <p>In the context of the <strong>B.R.I.D.G.E. Methodâ„¢</strong>, we view the BBB as a primary mediator of the <strong>Root Cause (R)</strong> of cognitive and psychiatric symptoms. When systemic inflammation (driven by the gut, toxins, or latent infections discussed in Lessons 2-5) becomes chronic, the tight junction proteins (Claudins and Occludins) of the BBB degrade. This phenomenon, colloquially termed <span class="highlight">"Leaky Brain,"</span> allows the infiltration of peripheral cytokines, T-cells, and even pathogens into the brain parenchyma.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Feature</th>
                        <th>Intact BBB (Homeostasis)</th>
                        <th>Permeable BBB (Neuro-inflammation)</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Tight Junctions</strong></td>
                        <td>High expression of Occludin/Claudin-5</td>
                        <td>Downregulated or fragmented proteins</td>
                    </tr>
                    <tr>
                        <td><strong>Astrocyte Role</strong></td>
                        <td>Supporting neuronal metabolism</td>
                        <td>Reactive astrogliosis; cytokine release</td>
                    </tr>
                    <tr>
                        <td><strong>Immune Traffic</strong></td>
                        <td>Highly restricted; immune surveillance</td>
                        <td>Massive infiltration of Macrophages & Neutrophils</td>
                    </tr>
                    <tr>
                        <td><strong>Clinical Presentation</strong></td>
                        <td>Mental clarity, stable mood</td>
                        <td>Brain fog, "Sickness Behavior," depression</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section2">2. Microglial Activation & The "Priming" Phenomenon</h2>
        <p>Microglia are the resident macrophages of the CNS, comprising approximately <span class="stat-highlight">10-15% of all cells in the brain</span>. Under normal conditions, they exist in a "surveying" state, using long processes to scan the environment for debris or synapses that need pruning. However, when the BBB is breached or systemic cytokines (like TNF-Î± and IL-1Î²) enter the brain, microglia undergo a morphological and functional shift.</p>

        <h3>M1 vs. M2 Polarization</h3>
        <p>Similar to peripheral macrophages, microglia can polarize into two primary phenotypes:</p>
        <ul>
            <li><strong>M1 (Pro-inflammatory):</strong> Produces ROS (Reactive Oxygen Species), Nitric Oxide, and inflammatory cytokines. While necessary for acute infection, chronic M1 activation leads to neuronal apoptosis and synaptic loss.</li>
            <li><strong>M2 (Anti-inflammatory/Repair):</strong> Produces IL-10 and TGF-Î², promoting tissue repair and neurogenesis.</li>
        </ul>

        <p>A critical concept for the Integrative Practitioner is <span class="highlight">Microglial Priming</span>. Previous insultsâ€”such as a traumatic brain injury (TBI), chronic mold exposure (Lesson 5), or severe viral infectionâ€”can "prime" microglia. These cells remain in a hyper-excitable state. A subsequent minor stressor (like a common cold or psychological stress) then triggers an exaggerated, neurotoxic inflammatory response. This explains why some patients experience "long-haul" symptoms or sudden cognitive decline after seemingly minor events.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: Post-Viral Neuro-inflammation</p>
                    <p style="color: white; margin: 0; font-size: 13px;">Root Cause Analysis (R) in Action</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">EH</div>
                    <div class="patient-info">
                        <h4>Elena H., 42</h4>
                        <p>Symptoms: Severe executive dysfunction, "brain fog," and new-onset anxiety 6 months post-COVID-19.</p>
                    </div>
                </div>
                <p><strong>Assessment:</strong> Elenaâ€™s labs showed elevated hs-CRP (4.2 mg/L) and high serum Zonulin. Her cognitive testing showed significant deficits in processing speed.</p>
                <p><strong>Intervention:</strong> Focused on BBB stabilization using high-dose Luteolin and Baicalein (to inhibit microglial M1 shift), along with 3g/day of EPA/DHA and a strict anti-inflammatory diet.</p>
                <p><strong>Outcome:</strong> Within 12 weeks, hs-CRP dropped to 0.8 mg/L. Elena reported an "80% clearance of the fog" and was able to return to her role as a software engineer.</p>
            </div>
        </div>

        <h2 id="section3">3. The Kynurenine Pathway: The "Tryptophan Steal"</h2>
        <p>One of the most profound mechanisms linking the immune system to mental health is the <span class="highlight">Kynurenine Pathway</span>. Tryptophan is the essential amino acid precursor to Serotonin. However, in the presence of inflammatory cytokines (specifically IFN-Î³), the body activates enzymes called IDO (Indoleamine 2,3-dioxygenase) and TDO.</p>

        <p>These enzymes "shunt" Tryptophan away from Serotonin production and toward the production of Kynurenine. This creates a double-edged sword for the brain:</p>
        <ol>
            <li><strong>Serotonin Depletion:</strong> Leading to depression, insomnia, and anxiety.</li>
            <li><strong>Neurotoxicity:</strong> Kynurenine is further metabolized into <span class="highlight">Quinolinic Acid</span>, a potent NMDA receptor agonist. Excessive Quinolinic Acid causes excitotoxicityâ€”essentially "frying" neurons through calcium over-influx.</li>
        </ol>

        <p>A 2022 meta-analysis of 32 studies (n=2,140) found that patients with Major Depressive Disorder had significantly higher Kynurenine-to-Tryptophan ratios compared to healthy controls (p < 0.001), confirming that depression is often a <span class="highlight">metabolic manifestation of neuro-inflammation</span> rather than a simple "chemical imbalance."</p>

        <h2 id="section4">4. Biomarkers of "Leaky Brain" (Data-Driven Decisions)</h2>
        <p>In the <strong>Data-Driven Decisions (D)</strong> phase of the B.R.I.D.G.E. Methodâ„¢, we move beyond subjective symptoms to objective quantification. While a direct biopsy of the BBB is impossible in clinical practice, we use surrogate serum markers to assess integrity.</p>

        <ul>
            <li><strong>S100B:</strong> A calcium-binding protein primarily found in astrocytes. When the BBB is compromised, S100B leaks into the systemic circulation. Levels > 0.15 Âµg/L are often associated with acute BBB disruption or neurodegeneration.</li>
            <li><strong>Zonulin:</strong> While primarily known for gut permeability, Zonulin is also expressed in the brain. High serum Zonulin correlates with increased BBB permeability, as the tight junction architecture is similar in both barriers.</li>
            <li><strong>GFAP (Glial Fibrillary Acidic Protein):</strong> A marker of astrocyte damage or "activation." Elevated levels are found in TBI, stroke, and chronic neuro-inflammatory states.</li>
            <li><strong>Kynurenine/Tryptophan Ratio:</strong> Available through advanced functional metabolic testing, this ratio indicates the degree of "neuro-inflammatory shunting."</li>
        </ul>

        <h2 id="section5">5. The Glymphatic System: The Brain's Nightly Cleaning Crew</h2>
        <p>If neuro-inflammation is the "fire," the <span class="highlight">Glymphatic System</span> is the "sprinkler system." Discovered relatively recently (Maiken Nedergaard, 2012), this system facilitates the clearance of metabolic wasteâ€”including Amyloid-beta and Tau proteinsâ€”from the CNS.</p>

        <p>The glymphatic system is primarily active during deep (slow-wave) sleep. During this phase, the extracellular space in the brain increases by <span class="stat-highlight">up to 60%</span>, allowing cerebrospinal fluid (CSF) to flush through the brain parenchyma, driven by the pulsation of arteries.</p>

        <h3>Optimization Strategies for Practitioners:</h3>
        <ul>
            <li><strong>Sleep Architecture:</strong> Prioritizing deep sleep is non-negotiable for neuro-immunology. Chronic insomnia is effectively a "waste management strike" in the brain.</li>
            <li><strong>Sleeping Position:</strong> Research indicates that <strong>lateral (side) sleeping</strong> may be more efficient for glymphatic clearance than supine (back) or prone (stomach) positions.</li>
            <li><strong>Circadian Alignment:</strong> Melatonin is not just a sleep hormone; it is a potent glymphatic stimulator and neuro-protective antioxidant.</li>
        </ul>

        <h2 id="section6">6. Clinical Protocols: The B.R.I.D.G.E. Framework</h2>
        <p>When <strong>Guiding the Journey (G)</strong> for a patient with neuro-inflammation, the practitioner must address both the "influx" (BBB/Microglia) and the "efflux" (Glymphatic system).</p>

        <div class="principle-card">
            <div class="principle-title">Step 1: Quench the Fire (Microglial Inhibition)</div>
            <div class="principle-text">
                Utilize polyphenols that cross the BBB. <strong>Luteolin</strong> and <strong>Apigenin</strong> have been shown in multiple studies to inhibit the NF-ÎºB pathway in microglia, reducing the production of IL-6 and TNF-Î±.
            </div>
        </div>

        <div class="principle-card">
            <div class="principle-title">Step 2: Seal the Barrier (BBB Integrity)</div>
            <div class="principle-text">
                Address systemic drivers. If the gut is "leaky," the brain will be too. Support tight junctions with <strong>Sulforaphane</strong> (which activates Nrf2) and ensure adequate <strong>Vitamin D3</strong> levels (target 50-80 ng/mL), as Vitamin D is a crucial regulator of BBB proteins.
            </div>
        </div>

        <div class="principle-card">
            <div class="principle-title">Step 3: Redirect the Shunt (Kynurenine Support)</div>
            <div class="principle-text">
                <strong>Vitamin B6 (P5P)</strong> is a necessary cofactor for the enzymes that move Kynurenine toward Kynurenic Acid (neuroprotective) rather than Quinolinic Acid (neurotoxic).
            </div>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">Why does systemic inflammation often lead to a "Serotonin deficiency" that is resistant to standard SSRI therapy?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Because the inflammation activates the IDO enzyme, which shunts Tryptophan toward the Kynurenine pathway. SSRIs cannot work effectively if the raw material (Tryptophan) is being stolen to create neurotoxic Quinolinic Acid instead of Serotonin.</div>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">What is the clinical significance of "Microglial Priming"?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Priming means the microglia are stuck in a hyper-responsive state due to a past insult. This causes them to over-react to minor future stressors, leading to chronic neuro-inflammation and cognitive symptoms that seem disproportionate to the trigger.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>The BBB is a dynamic interface; its permeability ("Leaky Brain") is a primary driver of the PNI axis dysfunction.</li>
                <li>Microglia are the brain's immune sentinels; chronic M1 activation leads to "collateral damage" of healthy neurons.</li>
                <li>The Kynurenine Pathway explains the biochemical link between systemic inflammation and psychiatric symptoms like depression.</li>
                <li>Glymphatic clearance occurs primarily during deep sleep; lifestyle interventions must prioritize sleep quality and position.</li>
                <li>Markers like S100B and the Kynurenine/Tryptophan ratio provide a data-driven map for neuro-immunological recovery.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Nedergaard, M. (2013). "Garbage Truck of the Brain." <i>Science</i>.</li>
                <li>Dantzer, R. et al. (2008). "From inflammation to sickness behavior: implications for depression." <i>Nature Reviews Neuroscience</i>.</li>
                <li>Oâ€™Rourke, et al. (2022). "The Kynurenine Pathway in Major Depressive Disorder: A Systematic Review and Meta-analysis." <i>Journal of Clinical Psychiatry</i>.</li>
                <li>Banks, W.A. (2015). "The Blood-Brain Barrier in Neuroinflammation." <i>Molecular Neurobiology</i>.</li>
                <li>Lyman, M. et al. (2014). "Neuroinflammation: The role and consequences of microglia." <i>Immunology Letters</i>.</li>
                <li>Raison, C.L. et al. (2013). "A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression." <i>JAMA Psychiatry</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Integrative Medicine Practitioner Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. The B.R.I.D.G.E. Methodâ„¢ is a proprietary framework.</p>
        </footer>
    </div>
</body>

</html>